Galmed Pharmaceuticals Achieves Significant Milestone with AM-001 Study of Aramchol Meglumine Galmed Pharmaceuticals has announced promising preliminary results from the AM-001 study, evaluating the effective Aramchol Meglumine formulation for NASH treatment.

Galmed Pharmaceuticals Achieves Significant Milestone with AM-001 Study of Aramchol Meglumine #Israel #Tel_Aviv #NASH #Aramchol #Galmed